Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsAccesswire • 06/22/23
Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European UnionAccesswire • 06/08/23
Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot CareAccesswire • 04/11/23
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in PhiladelphiaAccesswire • 03/28/23
Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade DisinfectantAccesswire • 03/02/23
Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South KoreaAccesswire • 01/31/23
Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx ProductsAccesswire • 01/25/23
Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical SpasAccesswire • 01/04/23
Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United StatesAccesswire • 10/27/22
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, GermanyAccesswire • 10/06/22
Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical SupplyAccesswire • 08/02/22
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial ResultsAccesswire • 07/13/22
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19Business Wire • 06/01/22
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.Business Wire • 05/03/22